[Meglumine acridonacetate and complex therapy of patients with newly identified advanced pulmonary tuberculosis].
Antibiot Khimioter
; 59(5-6): 15-9, 2014.
Article
em Ru
| MEDLINE
| ID: mdl-25552039
ABSTRACT
Clinical and immunological efficacy of meglumine acridonacetate (cycloferon) tablets was evaluated in complex treatment of patients with newly diagnosed advanced pulmonary tuberculosis. It was shown that the use of cycloferon according to our scheme increased the efficacy of the therapy (earlier disappearance of the disease symptoms and bacteria isolation, shorter-terms of cavern healing, more pronounced positive radiographic dynamics vs. the patients under the etiotropic therapy). The use of cycloferon normalized the number of gamma interferon receptors, increased the gamma interferon serum levels, reduced the incidence of the side effects (liver damage) due to the use of TB drugs. Such a use of cycloferon was cost effective. The use of sycloferon is possible in the complex treatment of outpatients with advanced pulmonary tuberculosis.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Tuberculose Pulmonar
/
Acridinas
/
Indutores de Interferon
/
Pulmão
Idioma:
Ru
Ano de publicação:
2014
Tipo de documento:
Article